HEALTHCARE 4.0
FDA Commissioner Scott Gottleib , upon the release of the guidelines .
“ Overall , it will help manufacturers bring their innovations to market more efficiently by providing a transparent process for future submissions and making sure our regulatory approach is properly tailored to the unique opportunities and challenges posed by this promising new technology .” “ Promising new technology ” may even be an understatement . It ’ s estimated that 100,000 knee replacement surgeries are now completed each year using 3D-printed , patient-matched surgical guides – just one specific application within the entirety of the industry .
Lauralyn McDaniel is Industry Manager of Medical Device Manufacturing for not-for-profit SME and she is as enthusiastic as anyone about the role 3D printing has to play in medicine moving forward .
“ I would not be surprised if more than a quarter of hospital patients globally will be directly impacted by the technology in 10 years ,” she says .
“ Medical applications have always been a leader in using the technology for end-use . With the ability to build from medical imaging data
“ With the United States ’ Food and Drug Administration choosing to release the first “ comprehensive technical framework ” to advise manufacturers creating medical products on 3D printers , it seems that the technology is now here to stay ”
LAURALYN MCDANIEL Industry Manager of Medical Device Manufacturing
to create truly personalised tools and devices , AM3DP ( Advanced Materials & 3D Printing ) is an enabler for precision medicine .
“ From anatomic models to support patient education to developing patient-matched devices to treat rare diseases like Tuberculous Meningitis , I think the entire healthcare industry is beginning to understand the impact it can have .” No doubt , the ability to match
18 February 2018